To better understand the relationship between ctDNA TF and imaging and RECIST 1.1, we analyzed the sum of (target) lesions longest diameter (SLD) as a proxy for tumor burden at both pre‐treatment and on‐treatment timepoints. Here, TF is linked to neoplasm.